Recall D-0251-2026

US Class II Ongoing · initiated 2025-12-18

Recalling firm

Imprimis NJOF, LLC, NJ

Product

Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.

Reason for recall

Presence of particulate matter - Glass like particles.

← All recalls